TY - JOUR
T1 - Screening collagenase activity in bacterial lysate for directed enzyme applications
AU - Tohar, Ran
AU - Ansbacher, Tamar
AU - Sher, Inbal
AU - Afriat‐jurnou, Livnat
AU - Weinberg, Evgeny
AU - Gal, Maayan
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8/2
Y1 - 2021/8/2
N2 - Collagenases are essential enzymes capable of digesting triple‐helical collagen under physiological conditions. These enzymes play a key role in diverse physiological and pathophysiological processes. Collagenases are used for diverse biotechnological applications, and it is thus of major interest to identify new enzyme variants with improved characteristics such as expression yield, stability, or activity. The engineering of new enzyme variants often relies on either rational protein design or directed enzyme evolution. The latter includes screening of a large randomized or semirational genetic library, both of which require an assay that enables the identification of improved variants. Moreover, the assay should be tailored for microplates to allow the screening of hundreds or thousands of clones. Herein, we repurposed the previously reported fluorogenic assay using 3,4‐dihydroxyphenylacetic acid for the quantitation of collagen, and applied it in the detection of bacterial collagenase activity in bacterial lysates. This enabled the screening of hundreds of E. coli colonies expressing an error‐prone library of collagenase G from C. histolyticum, in 96‐well deep-well plates, by measuring activity directly in lysates with collagen. As a proof‐of‐concept, a single variant exhibiting higher activity than the starting‐point enzyme was expressed, purified, and characterized biochemically and computationally. This showed the feasibility of this method to support medium‐high throughput screening based on direct evaluation of collagenase activity.
AB - Collagenases are essential enzymes capable of digesting triple‐helical collagen under physiological conditions. These enzymes play a key role in diverse physiological and pathophysiological processes. Collagenases are used for diverse biotechnological applications, and it is thus of major interest to identify new enzyme variants with improved characteristics such as expression yield, stability, or activity. The engineering of new enzyme variants often relies on either rational protein design or directed enzyme evolution. The latter includes screening of a large randomized or semirational genetic library, both of which require an assay that enables the identification of improved variants. Moreover, the assay should be tailored for microplates to allow the screening of hundreds or thousands of clones. Herein, we repurposed the previously reported fluorogenic assay using 3,4‐dihydroxyphenylacetic acid for the quantitation of collagen, and applied it in the detection of bacterial collagenase activity in bacterial lysates. This enabled the screening of hundreds of E. coli colonies expressing an error‐prone library of collagenase G from C. histolyticum, in 96‐well deep-well plates, by measuring activity directly in lysates with collagen. As a proof‐of‐concept, a single variant exhibiting higher activity than the starting‐point enzyme was expressed, purified, and characterized biochemically and computationally. This showed the feasibility of this method to support medium‐high throughput screening based on direct evaluation of collagenase activity.
KW - Bacterial lysate screening
KW - Collagenase
KW - Directed enzyme evolution
KW - Enzymatic assay
KW - Molecular dynamics
KW - Protein expression
UR - http://www.scopus.com/inward/record.url?scp=85112595993&partnerID=8YFLogxK
U2 - 10.3390/ijms22168552
DO - 10.3390/ijms22168552
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34445258
AN - SCOPUS:85112595993
SN - 1661-6596
VL - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 16
M1 - 8552
ER -